CSL : Real-World Evidence Study Proves Effectiveness Of Cell

CSL : Real-World Evidence Study Proves Effectiveness Of Cell-Based Quadrivalent Influenza Vaccines

CSL Seqirus, a subsidiary of CSL Ltd. (CSL.AX), Thursday said that a real-world evidence study shows that a cell-based quadrivalent influenza vaccine has been more effective than an egg-based quadrivalent influenza vaccine over three consecutive influenza seasons in the U.

Related Keywords

Gregg Sylvester , Head Of Medical Affairs , Forum Infectious Diseases , Open Forum Infectious Diseases , Chief Health Officer , Medical Affairs , Csl Seqirus , Sl Seqirus Influenza Vaccine , Sl Seqirus Cell Based Quadrivalent Flu Vaccine , Open Forum Infectious Disease ,

© 2025 Vimarsana